AU2002329784A1 - Molecules for disease detection and treatment - Google Patents
Molecules for disease detection and treatmentInfo
- Publication number
- AU2002329784A1 AU2002329784A1 AU2002329784A AU2002329784A AU2002329784A1 AU 2002329784 A1 AU2002329784 A1 AU 2002329784A1 AU 2002329784 A AU2002329784 A AU 2002329784A AU 2002329784 A AU2002329784 A AU 2002329784A AU 2002329784 A1 AU2002329784 A1 AU 2002329784A1
- Authority
- AU
- Australia
- Prior art keywords
- molecules
- treatment
- disease detection
- disease
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31311501P | 2001-08-17 | 2001-08-17 | |
US60/313,115 | 2001-08-17 | ||
US31678501P | 2001-08-31 | 2001-08-31 | |
US60/316,785 | 2001-08-31 | ||
US32340701P | 2001-09-17 | 2001-09-17 | |
US60/323,407 | 2001-09-17 | ||
US32602201P | 2001-09-28 | 2001-09-28 | |
US60/326,022 | 2001-09-28 | ||
US37070702P | 2002-04-05 | 2002-04-05 | |
US60/370,707 | 2002-04-05 | ||
US37986202P | 2002-05-10 | 2002-05-10 | |
US60/379,862 | 2002-05-10 | ||
PCT/US2002/026411 WO2003016497A2 (en) | 2001-08-17 | 2002-08-16 | Molecules for disease detection and treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002329784A1 true AU2002329784A1 (en) | 2003-03-03 |
Family
ID=27559694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002329784A Abandoned AU2002329784A1 (en) | 2001-08-17 | 2002-08-16 | Molecules for disease detection and treatment |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002329784A1 (en) |
WO (1) | WO2003016497A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE427961T1 (en) * | 2001-12-07 | 2009-04-15 | Nissui Pharm Co Ltd | GENE AND PROTEIN ASSOCIATED WITH FAT CELL DIFFERENTIATION |
US7442685B2 (en) | 2003-06-13 | 2008-10-28 | The University Of North Carolina At Chapel Hill | DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia |
DE602004023766D1 (en) * | 2004-08-31 | 2009-12-03 | Univ North Carolina | DOT1-HISTON METHYLTRANSFERASES AS A TARGET FOR IDENTIFYING THERAPEUTICS AGAINST LEUKEMIA |
EP1974055A4 (en) | 2006-01-20 | 2010-01-27 | Univ North Carolina | Diagnostic and therapeutic targets for leukemia |
PE20171640A1 (en) | 2010-09-22 | 2017-11-09 | Alios Biopharma Inc | REPLACED NUCLEOTIDE ANALOGS |
CA2860234A1 (en) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
NZ631601A (en) | 2012-03-21 | 2016-06-24 | Alios Biopharma Inc | Solid forms of a thiophosphoramidate nucleotide prodrug |
US9012427B2 (en) | 2012-03-22 | 2015-04-21 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
WO2017180984A1 (en) * | 2016-04-14 | 2017-10-19 | The Texas A&M University System | First trimester epigenetic and microrna biomarkers for preeclampsia |
WO2022212928A1 (en) * | 2021-04-02 | 2022-10-06 | The Regents Of The University Of California | Modified viruses and viral particles, methods of making, and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1314371A (en) * | 2000-03-17 | 2001-09-26 | 上海博德基因开发有限公司 | New polypeptide-human retinaldehyde binding proteing 39 and polynucleotide for coding such polypeptide |
-
2002
- 2002-08-16 AU AU2002329784A patent/AU2002329784A1/en not_active Abandoned
- 2002-08-16 WO PCT/US2002/026411 patent/WO2003016497A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003016497A2 (en) | 2003-02-27 |
WO2003016497A3 (en) | 2003-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002338265A1 (en) | Molecules for disease detection and treatment | |
AU2001255655A1 (en) | Treatment analysis systems and methods | |
AU2002258388A1 (en) | Narc8 programmed cell-death-associated molecules and uses thereof | |
AU2002329784A1 (en) | Molecules for disease detection and treatment | |
AU2002318356A1 (en) | Protein modification and maintenance molecules | |
AU2002349268A1 (en) | Medicine for preventing and treating bromidrosis | |
AU2001275990A1 (en) | 16816 and 16839, novel human phospholipase c molecules and uses therefor | |
AU2002364890A1 (en) | Molecules for disease detection and treatment | |
AU2001241709A1 (en) | Molecules for disease detection and treatment | |
AU2002253883A1 (en) | Protein modification and maintenance molecules | |
AU2003205174A1 (en) | Molecules for disease detection and treatment | |
AU2002327945A1 (en) | Human delta-n p73 molecules and uses thereof | |
AU2002347899A1 (en) | Molecules for disease detection and treatment | |
AU2002243539A1 (en) | Molecules for disease detection and treatment | |
GB0115780D0 (en) | Therapeutic molecules and uses thereof | |
AU2002359567A1 (en) | Molecules for disease detection and treatment | |
AU2002248723A1 (en) | Molecules for disease detection and treatment | |
AU2002239543A1 (en) | Molecules for disease detection and treatment | |
AU2002320630A1 (en) | Detecting and treating reproductive tract disorders | |
AU2002343515A1 (en) | Protein modification and maintenance molecules | |
AU5319400A (en) | Molecules for disease detection and treatment | |
AU2002320026A1 (en) | Molecules for disease detection and treatment | |
AU2003231245A1 (en) | Molecules for disease detection and treatment | |
EP1390410A4 (en) | Molecules for disease detection and treatment | |
AU2002312075A1 (en) | Molecules for disease detection and treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |